{
    "organizations": [],
    "uuid": "b90f99af8b67480a62139620da7f393da19059e1",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/04/26/globe-newswire-teligent-inc-to-hold-conference-call-for-first-quarter-2018-results.html",
    "ord_in_thread": 0,
    "title": "Teligent, Inc. to Hold Conference Call for First Quarter 2018 Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BUENA, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1 st quarter 2018 financial results and business update.\nThe Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.\nThis call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com .\nAbout Teligent, Inc.\nTeligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com .\nContact :\nDamian Finio\nTeligent, Inc.\n(856) 336-9117\nwww.teligent.com\nSource:Teligent, Inc.",
    "published": "2018-04-26T22:15:00.000+03:00",
    "crawled": "2018-04-26T22:31:13.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "buena",
        "april",
        "globe",
        "newswire",
        "teligent",
        "nasdaq",
        "tlgt",
        "new",
        "specialty",
        "generic",
        "pharmaceutical",
        "company",
        "announced",
        "company",
        "hold",
        "conference",
        "call",
        "et",
        "monday",
        "may",
        "discus",
        "st",
        "quarter",
        "financial",
        "result",
        "business",
        "update",
        "company",
        "invite",
        "listen",
        "call",
        "dialing",
        "international",
        "participant",
        "call",
        "participant",
        "ask",
        "join",
        "teligent",
        "call",
        "call",
        "available",
        "via",
        "webcast",
        "accessed",
        "investor",
        "relation",
        "section",
        "teligent",
        "website",
        "teligent",
        "teligent",
        "specialty",
        "generic",
        "pharmaceutical",
        "company",
        "mission",
        "leading",
        "player",
        "specialty",
        "generic",
        "prescription",
        "drug",
        "market",
        "learn",
        "website",
        "contact",
        "damian",
        "finio",
        "teligent",
        "source",
        "teligent",
        "inc"
    ]
}